ES8602255A1 - Un procedimiento para detectar y-o determinar un aglomerado formado por reaccion entre un agente de union especifico y la correspondiente sustancia aceptora - Google Patents

Un procedimiento para detectar y-o determinar un aglomerado formado por reaccion entre un agente de union especifico y la correspondiente sustancia aceptora

Info

Publication number
ES8602255A1
ES8602255A1 ES537926A ES537926A ES8602255A1 ES 8602255 A1 ES8602255 A1 ES 8602255A1 ES 537926 A ES537926 A ES 537926A ES 537926 A ES537926 A ES 537926A ES 8602255 A1 ES8602255 A1 ES 8602255A1
Authority
ES
Spain
Prior art keywords
reaction
binding agent
specific binding
direct
acceptor substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES537926A
Other languages
English (en)
Other versions
ES537926A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of ES537926A0 publication Critical patent/ES537926A0/es
Publication of ES8602255A1 publication Critical patent/ES8602255A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/559—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody through a gel, e.g. Ouchterlony technique
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Communication Control (AREA)
  • Details Of Television Scanning (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

METODO PARA LA DETECCION Y/O DETERMINACION EN ENSAYOS DE TRANSFERENCIA POR SUPERPOSICION DE UN AGLOMERADO FORMADO POR UN AGENTE DE UNION Y LA CORRESPONDIENTE SUSTANCIA ACEPTORA. COMPRENDE LAS ETAPAS DE: A) INMOVILIZAR LA SUSTANCIA ACEPTORA SOBRE UNA MATRIZ INMOVILIZANTE, B) PONER EN CONTACTO DICHA MATRIZ INMOVILIZANTE CON UNA PROTEINA DE UNION ESPECIFICA MARCADA CON PARTICULAS METALICAS COLOIDALES; O BIEN CON UNA PROTEINA DE UNION ESPECIFICA NO MARCADA Y POSTERIORMENTE CON UNA PROTEINA MARCADA CON METAL COLOIDAL ESPECIFICA PARA LA PROTEINA NO MARCADA, Y C) DETECTAR LA SEÑAL COLOREADA EN EL SITIO DE REACCION EN LA SUPERFICIE DE LA MATRIZ INMOVILIZANTE DESPUES DE HABER APLICADO UN REVELADOR FISICO QUE CONTIENE PLATA. LAS PARTICULAS METALICAS COLOIDALES ESTAN CONSTITUIDAS POR ORO, PLATA, PLATINO O COMPUESTOS DE ESTOS METALES O COMPUESTOS DE HIERRO O COBRE CON UN TAMAÑO DE PARTICULA COMPRENDIDO ENTRE 3 NM Y 100 NM.
ES537926A 1983-11-25 1984-11-23 Un procedimiento para detectar y-o determinar un aglomerado formado por reaccion entre un agente de union especifico y la correspondiente sustancia aceptora Expired ES8602255A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838331514A GB8331514D0 (en) 1983-11-25 1983-11-25 Visualization method

Publications (2)

Publication Number Publication Date
ES537926A0 ES537926A0 (es) 1985-11-01
ES8602255A1 true ES8602255A1 (es) 1985-11-01

Family

ID=10552346

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537926A Expired ES8602255A1 (es) 1983-11-25 1984-11-23 Un procedimiento para detectar y-o determinar un aglomerado formado por reaccion entre un agente de union especifico y la correspondiente sustancia aceptora

Country Status (19)

Country Link
US (1) US4775636A (es)
EP (1) EP0158746B1 (es)
JP (2) JPH0643998B2 (es)
KR (1) KR890001131B1 (es)
AT (1) ATE64468T1 (es)
AU (1) AU583484B2 (es)
CA (1) CA1253422A (es)
CY (1) CY1759A (es)
DE (1) DE3484710D1 (es)
DK (1) DK160108C (es)
ES (1) ES8602255A1 (es)
FI (1) FI80345C (es)
GB (1) GB8331514D0 (es)
HK (1) HK14894A (es)
IL (1) IL73607A (es)
NO (1) NO163754C (es)
NZ (1) NZ210309A (es)
PT (1) PT79533A (es)
ZA (1) ZA849182B (es)

Families Citing this family (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
GB8415998D0 (en) * 1984-06-22 1984-07-25 Janssen Pharmaceutica Nv Staining method
US5958790A (en) * 1984-12-20 1999-09-28 Nycomed Imaging As Solid phase transverse diffusion assay
US5512332A (en) * 1985-10-04 1996-04-30 Immunivest Corporation Process of making resuspendable coated magnetic particles
US5137827A (en) * 1986-03-25 1992-08-11 Midwest Research Technologies, Inc. Diagnostic element for electrical detection of a binding reaction
US4837145A (en) * 1986-06-09 1989-06-06 Liotta Lance A Layered immunoassay using antibodies bound to transport particles to determine the presence of an antigen
US5514602A (en) * 1986-06-09 1996-05-07 Ortho Diagnostic Systems, Inc. Method of producing a metal sol reagent containing colloidal metal particles
AU602694B2 (en) * 1986-06-09 1990-10-25 Ortho Diagnostic Systems Inc. Improved colloidal gold membrane assay
AU7385387A (en) * 1986-06-09 1987-12-10 Ortho Diagnostic Systems Inc. Immunoassay using detection of colloidal gold
EP0254081A3 (en) * 1986-06-30 1988-04-20 Yuko Yoneda Method of detecting specific protein
US5491098A (en) * 1987-03-09 1996-02-13 Janssen Pharmaceutica N.V. Method for depositing metal particles on a marker
CA1340803C (en) * 1987-03-09 1999-10-26 Janssen Pharmaceutica N.V. Method for depositing metal particles on a marker
USRE38430E1 (en) 1987-03-27 2004-02-17 Becton, Dickinson And Company Solid phase chromatographic immunoassay
DE3856421T2 (de) 1987-04-27 2000-12-14 Unilever Nv Spezifische Bindungstestverfahren
US4962023A (en) 1987-06-22 1990-10-09 Louisiana State University, Agricultural And Mechanical College Single incubation immuno sorbent assay method using particle labels to detect test antigen specific antibodies in presence of other antibodies
US5120643A (en) * 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
JP2581566B2 (ja) * 1987-09-30 1997-02-12 和光純薬工業株式会社 鉄コロイド標識抗体及びその製法並びにこれを用いる組織細胞化学的検出方法
US5006464A (en) * 1987-10-01 1991-04-09 E-Y Laboratories, Inc. Directed flow diagnostic device and method
US5571667A (en) * 1987-10-01 1996-11-05 Chu; Albert E. Elongated membrane flow-through diagnostic device and method
ES2039025T3 (es) * 1987-11-16 1993-08-16 Janssen Pharmaceutica N.V. Un agregado para determinar sustancias combinables.
NL8702769A (nl) * 1987-11-19 1989-06-16 Holland Biotechnology Werkwijze voor het bepalen in een testmonster van componenten van de reactie tussen een specifiek bindend eiwit en de bijbehorende bindbare stof onder toepassing van ten minste een gemerkte component, werkwijze voor het bereiden van de gemerkte component, en testkit voor de bepaling van immunocomponenten.
GB8800702D0 (en) * 1988-01-13 1988-02-10 Nycomed As Test method & reagent kit therefor
US4952517A (en) * 1988-02-08 1990-08-28 Hygeia Sciences, Inc. Positive step immunoassay
US5202267A (en) * 1988-04-04 1993-04-13 Hygeia Sciences, Inc. Sol capture immunoassay kit and procedure
JPH02504429A (ja) * 1988-05-23 1990-12-13 ガイ，ステファン リウマチ様関節炎の診断と治療
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
US5079172A (en) 1988-11-04 1992-01-07 Board Of Trustees Operating Michigan State University Method for detecting the presence of antibodies using gold-labeled antibodies and test kit
AU4647589A (en) * 1988-11-10 1990-05-28 Midwest Research Technologies, Inc. Method for electrical detection of a binding reaction
US5202268A (en) * 1988-12-30 1993-04-13 Environmental Diagnostics, Inc. Multi-layered test card for the determination of substances in liquids
US5028535A (en) * 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US6352862B1 (en) 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
ATE117804T1 (de) * 1989-06-05 1995-02-15 Janssen Pharmaceutica Nv Festphasen-test zur verwendung mit einem physikalischen entwickler.
GB8915512D0 (en) 1989-07-06 1989-08-23 Sec Dep For Health Silver enhanced gold-labelled immuno assay method
US5698271A (en) * 1989-08-22 1997-12-16 Immunivest Corporation Methods for the manufacture of magnetically responsive particles
US6352863B1 (en) 1990-01-19 2002-03-05 La Mina, Inc. Assay device
US5143852A (en) * 1990-09-14 1992-09-01 Biosite Diagnostics, Inc. Antibodies to ligand analogues and their utility in ligand-receptor assays
WO1992012428A1 (en) * 1991-01-11 1992-07-23 Quidel Corporation A one-step lateral flow nonbibulous assay
US5468648A (en) * 1991-05-29 1995-11-21 Smithkline Diagnostics, Inc. Interrupted-flow assay device
US5877028A (en) 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
US5607863A (en) * 1991-05-29 1997-03-04 Smithkline Diagnostics, Inc. Barrier-controlled assay device
US5869345A (en) * 1991-05-29 1999-02-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing conductive barrier
US6168956B1 (en) 1991-05-29 2001-01-02 Beckman Coulter, Inc. Multiple component chromatographic assay device
US5998220A (en) 1991-05-29 1999-12-07 Beckman Coulter, Inc. Opposable-element assay devices, kits, and methods employing them
EP0627954B1 (en) * 1992-02-25 1996-04-17 ANDERSEN, Peter Process for electroelution of a gel containing separated charged macromolecules, such as proteins or dna/rna, and an apparatus and means for use in the process
US5395754A (en) * 1992-07-31 1995-03-07 Hybritech Incorporated Membrane-based immunoassay method
US5340746A (en) * 1993-01-08 1994-08-23 Minnesota Mining And Manufacturing Company Composite reactive articles for the determination of cyanide
CA2105515A1 (en) * 1993-09-03 1995-03-04 Carlos A. Santizo Lescaille Visual immunoassay method for the detection of ligands, based on the use of opaque plastic supports
US5712172A (en) 1995-05-18 1998-01-27 Wyntek Diagnostics, Inc. One step immunochromatographic device and method of use
US6319676B1 (en) 1995-05-02 2001-11-20 Carter Wallace, Inc. Diagnostic detection device and method
US5691152A (en) * 1995-11-09 1997-11-25 E. R. Squibb & Sons, Inc. Stable avidin composition
US6551794B1 (en) 1995-11-09 2003-04-22 E. R. Squibb & Sons, Inc. Stable biotinylated biomolecule composition
US5795784A (en) 1996-09-19 1998-08-18 Abbott Laboratories Method of performing a process for determining an item of interest in a sample
US5856194A (en) 1996-09-19 1999-01-05 Abbott Laboratories Method for determination of item of interest in a sample
JP4068677B2 (ja) * 1996-10-25 2008-03-26 アークレイ株式会社 遺伝子の分析方法およびそれに用いる遺伝子分析用キット
JP4025833B2 (ja) * 1996-10-25 2007-12-26 アークレイ株式会社 遺伝子の分析方法およびそれに用いる遺伝子分析用キット並びに遺伝子分析装置
US7153651B1 (en) 1996-10-31 2006-12-26 Inverness Medical - Biostar, Inc. Flow-through optical assay devices providing laminar flow of fluid samples, and methods of construction thereof
US5879951A (en) 1997-01-29 1999-03-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing unidirectional flow
US6103536A (en) 1997-05-02 2000-08-15 Silver Lake Research Corporation Internally referenced competitive assays
US5939252A (en) 1997-05-09 1999-08-17 Lennon; Donald J. Detachable-element assay device
EP1121198A1 (en) * 1998-10-14 2001-08-08 Arizona Board of Regents Immobilized silver immunoassay system
IL126776A (en) * 1998-10-27 2001-04-30 Technion Res & Dev Foundation A method of investing gold
US6136610A (en) 1998-11-23 2000-10-24 Praxsys Biosystems, Inc. Method and apparatus for performing a lateral flow assay
US6136044A (en) * 1999-02-03 2000-10-24 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Stable coloring by in situ formation of micro-particles
EP1294749A2 (en) * 2000-03-09 2003-03-26 Heska Corporation Use of recombinant antigens to determine the immune status of an animal
US6699722B2 (en) 2000-04-14 2004-03-02 A-Fem Medical Corporation Positive detection lateral-flow apparatus and method for small and large analytes
DE10108359B4 (de) * 2001-02-21 2008-03-27 Enßlin, Walther, Dr. Nachweisverfahren für reduzierende Substanzen
WO2002100444A1 (en) * 2001-06-08 2002-12-19 Biosphere Medical Inc. Colloidal metal labelled microparticles, their production and use
US20030013084A1 (en) * 2001-07-12 2003-01-16 Berlock Aps Organometallic probe
WO2003075765A1 (en) * 2002-03-05 2003-09-18 Board Of Regents, The University Of Texas System Biospecific contrast agents
US7138468B2 (en) * 2002-03-27 2006-11-21 University Of Southern Mississippi Preparation of transition metal nanoparticles and surfaces modified with (CO)polymers synthesized by RAFT
AU2003274629B2 (en) * 2002-10-11 2009-03-12 Zbx Corporation Diagnostic devices
WO2005066613A1 (en) * 2003-12-31 2005-07-21 President And Fellows Of Harvard College Assay device and method
US7638093B2 (en) * 2004-01-28 2009-12-29 Dnt Scientific Research, Llc Interrupted flow rapid confirmatory immunological testing device and method
US7465587B2 (en) 2004-12-03 2008-12-16 Genzyme Corporation Diagnostic assay device
US20060292700A1 (en) * 2005-06-22 2006-12-28 Naishu Wang Diffused interrupted lateral flow immunoassay device and method
CN101184999B (zh) * 2005-05-23 2013-03-27 法迪亚股份有限公司 两步侧向流测定方法和设备
US20070015166A1 (en) * 2005-07-14 2007-01-18 Nilsen Thor W Lateral flow methods and devices for detection of nucleic acid binding proteins
WO2007061098A1 (ja) * 2005-11-25 2007-05-31 Japan Science And Technology Agency 分析方法及び分析装置
US7879623B2 (en) * 2006-03-31 2011-02-01 Guirguis Raouf A Integrated device for analyte, testing, confirmation, and donor identity verification
US8940527B2 (en) * 2006-03-31 2015-01-27 Lamina Equities Corp. Integrated device for analyte testing, confirmation, and donor identity verification
US7741103B2 (en) * 2006-03-31 2010-06-22 Guirguis Raouf A Integrated screening and confirmation device
US11906512B2 (en) 2006-03-31 2024-02-20 Zeus Diagnostics, LLC Integrated device for analyte testing, confirmation, and donor identity verification
US7569396B1 (en) 2006-09-08 2009-08-04 Purplecow Llc Caffeine detection using internally referenced competitive assays
US7919331B2 (en) * 2006-12-21 2011-04-05 Silver Lake Research Corporation Chromatographic test strips for one or more analytes
JP4870695B2 (ja) * 2008-02-12 2012-02-08 富士フイルム株式会社 メンブレン内の標識を洗浄、増幅、停止する方法
JP4980946B2 (ja) * 2008-02-12 2012-07-18 富士フイルム株式会社 ブロッティング検出方法
US8673644B2 (en) 2008-05-13 2014-03-18 Battelle Memorial Institute Serum markers for type II diabetes mellitus
US8476008B2 (en) * 2008-07-23 2013-07-02 Diabetomics, Llc Methods for detecting pre-diabetes and diabetes
US20100047913A1 (en) * 2008-08-19 2010-02-25 The Trustees Of The University Of Pennsylvania Colloidal Gold Single Reagent Quantitative Protein Assay
EP2391891A1 (en) 2009-01-27 2011-12-07 Proteogenix, Inc. Biomarkers for detection of neonatal sepsis in biological fluid
EP2391892B1 (en) 2009-01-30 2017-01-18 Mycartis N.V. Biomarker for diagnosis of acute heart failure and uses thereof
WO2010132447A2 (en) 2009-05-11 2010-11-18 Diabetomics, Llc Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
US8628979B2 (en) 2009-10-21 2014-01-14 Pronota N.V. MCAM as a biomarker for fluid homeostasis
CA2780976C (en) 2009-11-25 2020-03-31 Hologic, Inc. Detection of intraamniotic infection
JP6092092B2 (ja) 2010-03-26 2017-03-08 マイカーティス エヌ．ヴェ．ＭｙＣａｒｔｉｓ ＮＶ 腎機能障害、糸球体濾過速度、呼吸困難、急性心不全、左心室肥大、心線維症、子癇前症、妊娠関連蛋白尿のバイオマーカーとしてのｌｔｂｐ２
US20130045889A1 (en) 2010-04-13 2013-02-21 Pronota N.V. Biomarkers for hypertensive disorders of pregnancy
KR101787791B1 (ko) * 2010-04-14 2017-10-19 니토 보세키 가부시기가이샤 시료 중의 분석 대상 물질을 측정하기 위한 검사 기구 및 그것을 사용한 분석 대상 물질의 측정 방법
EP2576806B1 (en) 2010-05-26 2017-03-08 The Board of Trustees of the University of Illionis Personal glucose meters for detection and quantification of a broad range of analytes
US20130116151A1 (en) 2010-07-08 2013-05-09 Pronota N.V. Biomarker for hypertensive disorders of pregnancy
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
US20120142559A1 (en) 2010-12-06 2012-06-07 Pronota N.V. Biomarkers and parameters for hypertensive disorders of pregnancy
WO2013083781A2 (en) 2011-12-08 2013-06-13 Pronota N.V. Biomarkers and test panels useful in systemic inflammatory conditions
AU2012351504C1 (en) 2011-12-15 2018-04-26 Mycartis N.V. Biomarkers and parameters for preeclampsia
AU2012367247B2 (en) 2012-01-24 2018-04-05 Cd Diagnostics, Inc. System for detecting infection in synovial fluid
US20140248629A1 (en) * 2013-03-03 2014-09-04 Morteza Mahmoudi Gold nanoparticle based dipstick nano-biosensor for detecting plasmodium falciparum and plasmodium vivax and mehtod of synthesizing the same
US9383352B2 (en) 2014-03-26 2016-07-05 Diabetomics, Inc. Salivary protein glycosylation test for diagnosis and monitoring of diabetes
US20180011088A1 (en) 2015-01-29 2018-01-11 Neogen Corporation Methods for Immuno Chromatographic Assay Desensitization
WO2016172660A1 (en) 2015-04-23 2016-10-27 Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada, Reno Fungal detection using mannan epitope
CN108136051A (zh) 2015-08-04 2018-06-08 Cd诊断股份有限公司 检测不良局部组织反应(altr)坏死的方法
US10151749B2 (en) * 2015-08-05 2018-12-11 Alfaisal University Method and kit for the detection of microorganisms
US20200200735A9 (en) 2016-02-22 2020-06-25 Ursure, Inc. System and method for detecting therapeutic agents to monitor adherence to a treatment regimen
US20190120838A1 (en) 2016-04-13 2019-04-25 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and kits for the rapid detection of the escherichia coli o25b-st131 clone
US10564155B2 (en) 2017-01-27 2020-02-18 Raouf A Guirguis Dual swab fluid sample collection for split sample testing and fingerprint identification device
US12282029B2 (en) 2017-05-08 2025-04-22 MPB Fertility, Inc. Portable diagnostic system for ovulation cycle monitoring
US11061026B2 (en) 2017-02-17 2021-07-13 MFB Fertility, Inc. System of evaluating corpus luteum function by recurrently evaluating progesterone non-serum bodily fluids on multiple days
KR102582297B1 (ko) 2017-05-19 2023-09-25 필립모리스 프로덕츠 에스.에이. 대상체의 흡연 상태를 구별하기 위한 진단 테스트
WO2019152657A1 (en) 2018-02-03 2019-08-08 Simple Healthkit, Inc. Reliable, comprehensive, and rapid sexual health assessment
US12181465B2 (en) 2018-08-22 2024-12-31 MFB Fertility, Inc. Method for evaluating urine of a subject to estimate the fertile window by evaluating for the presence of analytes of estrogen and progesterone
US11300576B2 (en) 2019-01-29 2022-04-12 Arizona Board Of Regents On Behalf Of Arizona State University DARPin reagents that distinguish Alzheimer's disease and Parkinson's disease samples

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115198A (en) * 1974-02-11 1978-09-19 Coughlin Robert W Method of immobilization of biologically active organic substances including enzymes
IL49685A (en) * 1976-05-31 1978-10-31 Technion Res & Dev Foundation Specific binding assay method for determining the concentration of materials and reagent means therefor
US4208185A (en) * 1976-08-16 1980-06-17 Mitsubishi Chemical Industries Limited Method and apparatus for the measurement of antigens and antibodies
US4203724A (en) * 1976-08-16 1980-05-20 Mitsubishi Chemical Industries Limited Method and apparatus for the measurement of antigens and antibodies
SE431257B (sv) * 1977-11-03 1984-01-23 Du Pont Sett och anordning for immunanalys med magnetisk metall eller metalloxid som merksubstans
NL7807532A (nl) * 1978-07-13 1980-01-15 Akzo Nv Metaal-immunotest.
US4420558A (en) * 1981-02-12 1983-12-13 Janssen Pharmaceutica N.V. Bright field light microscopic method of enumerating and characterizing subtypes of white blood cells and their precursors
US4487839A (en) * 1983-01-05 1984-12-11 Ortho Diagnostic Systems Inc. Immunoassay methods employing patterns for the detection of soluble and cell surface antigens
CA1260827A (en) * 1984-08-31 1989-09-26 Richard C. Siegel Antibody-metal ion complexes

Also Published As

Publication number Publication date
ES537926A0 (es) 1985-11-01
FI844508A0 (fi) 1984-11-16
KR890001131B1 (ko) 1989-04-24
AU583484B2 (en) 1989-05-04
CY1759A (en) 1994-07-15
DE3484710D1 (de) 1991-07-18
EP0158746A3 (en) 1987-09-23
JP2601616B2 (ja) 1997-04-16
AU3582584A (en) 1985-05-30
IL73607A0 (en) 1985-02-28
US4775636A (en) 1988-10-04
CA1253422A (en) 1989-05-02
DK160108C (da) 1995-07-24
JPS60185160A (ja) 1985-09-20
DK557684A (da) 1985-05-26
EP0158746A2 (en) 1985-10-23
DK557684D0 (da) 1984-11-23
NO163754C (no) 1993-01-12
ATE64468T1 (de) 1991-06-15
HK14894A (en) 1994-03-04
JPH0643998B2 (ja) 1994-06-08
FI80345C (fi) 1992-11-16
NO844672L (no) 1985-05-28
ZA849182B (en) 1986-06-25
IL73607A (en) 1988-12-30
EP0158746B1 (en) 1991-06-12
NZ210309A (en) 1987-04-30
GB8331514D0 (en) 1984-01-04
FI80345B (fi) 1990-01-31
JPH0643162A (ja) 1994-02-18
NO163754B (no) 1990-04-02
DK160108B (da) 1991-01-28
KR850003728A (ko) 1985-06-26
FI844508L (fi) 1985-05-26
PT79533A (en) 1984-12-01

Similar Documents

Publication Publication Date Title
ES8602255A1 (es) Un procedimiento para detectar y-o determinar un aglomerado formado por reaccion entre un agente de union especifico y la correspondiente sustancia aceptora
EP0256932A3 (en) Use of oxidase enzyme systems in chemiluminescent assays
ATE49300T1 (de) Methode fuer einen heterogenen immunoassay und anordnung hierfuer.
ZA877719B (en) Immunoassay based on two enzyme inhibition system
ES2077061T3 (es) Metodo y reactivo para la determinacion de un material de analisis a traves de medios enzimaticos utilizando un sistema de compuesto ferricianido/ferrico.
ES485763A1 (es) Un metodo directo para la determinacion de hierro en suero sanguineo
AU1069483A (en) P-nitrophenol modified substrate and temperature independent buffer
ES8507692A1 (es) Un procedimiento para preparar un trazador para uso en ensayo no isotopico
FI862975A0 (fi) Foerfarande och reagens foer specifik bestaemning av bukspottkoertelns alfa-amylas.
GB1540728A (en) Polyiodothyronine immunoassay
ES8802076A1 (es) Un procedimiento para efectuar un ensayo de fijacion especifica ligada a un marcador.
DE3265522D1 (en) Method for preparing a chromogen reactive for determining the serum iron concentration and binding power, and the chromogen reactive obtained thereby
GB1509460A (en) Radioimmunoassay for renin activity
SG12594G (en) Visualization method for the direct or indirect detection of the reaction between a specific binding agent and the corresponding acceptor substance in blot overlay assays.
AU1398988A (en) Qualitative and quantitative determination of particulate antigens, in particular spores of clostridium tyrobutyricum
ES539598A1 (es) Un procedimiento para preparar un trazador cromogeno a base de fluoresceinamina conjugada con l-tiroxina
ES436168A1 (es) Un metodo de ensayo para determinar colorimetricamente la cantidad de un enzima presente en un medio biologico femeni-no.
ES8303698A1 (es) "metodo para la determinacion del nivel de transferrina en la sangre".

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050627